Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients

Table 4

Outcome.

Parameters	All (𝑛=32)	Responders (𝑛=17)	Nonresponders (𝑛=15)	𝑃 value
ICU length of stay—days	6 (1–62)	6 (1–23)	6 (2–62)	0.26
Sinus rhythm on ICU—discharge	23 (74%)	14 (88%)	9 (60%)	0.11
Survival	32 (100%)	17 (100%)	15 (100%)	1.00

Results are given as median (minimum–maximum) or numbers (percentages). Groups were compared with Fisher’s exact test or the Mann-Whitney 𝑈 test, as appropriate.